国家: 新加坡
语言: 英文
来源: HSA (Health Sciences Authority)
NEVIRAPINE
BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.
J05AG01
200 mg
TABLET
NEVIRAPINE 200 mg
ORAL
Prescription Only
BOEHRINGER INGELHEIM ELLAS A.E.
ACTIVE
1998-12-08
1 VIRAMUNE ® abcd COMPOSITION 1 immediate release tablet contains: 200mg 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one (= nevirapine anhydrous) Excipients: cellulose, lactose monohydrate, povidone K 25, sodium starch glycolate, silicia colloidal, magnesium stearate 1 ml oral suspension contains: 10mg 11-cyclopropyl-5, 11-dihydro-4-methyl-6H-dipyrido[3,2-b:2’,3’-e][1,4]diazepin-6-one (=nevirapine; as 10.35 mg nevirapine hemihydrate) Excipients: carbomer, methyl parahydroxybenzoate, propyl parahydroxybenzoate, sorbitol, sucrose, polysorbate 80, sodium hydroxide, purified water DESCRIPTION Tablet: white, oval biconvex tablet.One side is embossed with “54 193”, with a single bisect separating the “54” and “193”. The opposite side is marked with a BI company symbol. Suspension: white to off-white off homogeneous suspension. PHARMACOLOGICAL PROPERTIES Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1. Nevirapine binds directly to reverse transcriptase and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates. HIV-2 reverse transcriptase and eukaryotic DNA polymerases 阅读完整的文件
1 VIRAMUNE ® abcd COMPOSITION 1 immediate release tablet contains: 200mg 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one (= nevirapine anhydrous) Excipients: cellulose, lactose monohydrate, povidone K 25, sodium starch glycolate, silicia colloidal, magnesium stearate 1 ml oral suspension contains: 10mg 11-cyclopropyl-5, 11-dihydro-4-methyl-6H-dipyrido[3,2-b:2’,3’-e][1,4]diazepin-6-one (=nevirapine; as 10.35 mg nevirapine hemihydrate) Excipients: carbomer, methyl parahydroxybenzoate, propyl parahydroxybenzoate, sorbitol, sucrose, polysorbate 80, sodium hydroxide, purified water DESCRIPTION Tablet: white, oval biconvex tablet.One side is embossed with “54 193”, with a single bisect separating the “54” and “193”. The opposite side is marked with a BI company symbol. Suspension: white to off-white off homogeneous suspension. PHARMACOLOGICAL PROPERTIES Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1. Nevirapine binds directly to reverse transcriptase and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates. HIV-2 reverse transcriptase and eukaryotic DNA polymerases (such as human DNA polymerases α , β , γ , or δ ) are not inhibited by nevirapine. In clinical studies, VIRAMUNE has been associated with an increase in HDL- cholesterol and an overall improvement in the total to HDL-cholesterol ratio, which in the general population would be considered to be associated with a lower cardiovascular risk. However, in the absence of specific studies with VIRAMUNE on modifying the cardiovascular risk in HIV infected patients, the clinical impact of these findings is not known. The selection of antiretroviral drugs must be guided primarily by their antiviral efficacy. IN VITRO HIV SUSCEPTIBILITY: The in vitro antiviral activity of nevirapine has been measured in a variety of cell lines inc 阅读完整的文件